| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689588 | Kidney International Reports | 2016 | 11 Pages |
Abstract
The Genetic Contribution to Drug Induced Renal Injury (DIRECT) study will be the first observational cohort study to investigate the genetic determinants of DIKD. If the trial is positive, its findings will potentially translate into safer patient outcomes, by genotypic individualization of therapy and minimization of harm.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Linda Awdishu, Caroline M. Nievergelt, Andrew Davenport, Patrick T. Murray, Etienne Macedo, Jorge Cerda, Raj Chakaravarthi, Satish P. Ramachandra Rao, Arthur Holden, Stuart L. Goldstein, Ravindra L Mehta,